Tokyo, London, and Paris, May 27, 2025 - (JCN Newswire via SeaPRwire.com) - JCB and PayXpert, a pioneering omnichannel payment services provider based in Europe and in the UK, today announced a strategic partnership to enhance JCB’s card acceptance across European1 and UK markets. The collaboration promises a smoother payment experience for both merchants in the regions and international JCB Cardmembers.Through this collaboration, JCB’s 169 million cardmembers will enjoy greater convenience and accessibility across a wide range of businesses throughout Europe and in the UK. PayXpert's varied merchant network is covering diverse sectors such as retail, hospitality, tourism, and transport. This partnership ensures broader JCB Card acceptance, making it easier than ever for JCB Cardmembers to use their preferred payment method while traveling and spending in Europe and in the UK.By joining JCB's merchant community of 56 million worldwide, PayXpert is ideally positioned to facilitate JCB Card acceptance in Europe and in the UK and support the growth of its merchant partners. This partnership will also enable PayXpert’s merchants to tap into the growing number of JCB Cardmembers, mainly from Asia, who frequently travel and shop across Europe. This way, merchants will be able to cater for the needs of international travellers and offer a more seamless and tailored in-store payment experience, encouraging repeat business and fostering loyalty. The collaboration will also facilitate cross-border payments, further enhancing convenience for both merchants and cardmembers. Moreover, JCB Card acceptance on POS terminals is enabled at no additional setup cost, empowering merchants to tap into new revenue opportunities effortlessly.“We are delighted to announce our new collaboration with PayXpert to further expand JCB’s presence in the European and UK market,” said Ray Shinzawa, Managing Director, JCB International (Europe) Ltd. “This partnership aligns with our goals of providing JCB Cardmembers with a fast and secure payment experience, whenever they need it. By leveraging PayXpert’s extensive network and expertise, we will further increase our JCB Card acceptance, providing unparalleled convenience for our cardmembers travelling throughout Europe.”Nicolas Riegert, Co-founder & CEO, PayXpert added, “We are thrilled to welcome JCB to our network and offer our merchants access to a wider customer base. This partnership showcases our commitment to providing seamless and flexible payment solutions that meet the evolving needs of our clients. Inclusivity is at the core of PayXpert’s DNA, and by accepting international payment methods like JCB, we enable more global shoppers to enjoy a payment experience tailored to their preferences and habits. By welcoming JCB Cardmembers, our merchants can attract new customers, increase sales, and enhance their overall customer experience.”About JCB JCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 56 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 169 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide. For more information, please visit: www.global.jcb/en/About PayXpertPayXpert2 is a pioneer in omnichannel payments, subsidiary of Societe Generale group. We support local and international brands across various industries, providing services both online and in-store. We have developed services focused on revenue optimisation, performance enhancement, fraud prevention, as well as cross-border payments such as Discover or JCB, and alternative methods like Alipay+ and WeChat Pay. Our solutions also integrate inclusive features for the visually impaired. Our vision is to create a payment ecosystem that facilitates an inclusive commerce experience. www.payxpert.com MEDIA CONTACTS:JCB International (Europe) Ltd.Diana Lee: dlee@jcbeurope.euJCB (Head Office in Japan)Anna Takeda: Anna.Takeda@jcb.co.jp1 PayXpert Spain SL can facilitate the acceptance of JCB in the following countries in Europe: Austria, Belgium, Bulgaria, Cyprus, Estonia, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Czech Republic, Spain and Sweden.2 PayXpert is divided into PayXpert Limited and PayXpert Services Ltd, a subsidiary of the Societe Generale group, which includes PayXpert Spain SL and PayXpert France. PayXpert Limited is regulated by the FCA and licensed in the UK. PayXpert Spain is regulated by Banco de España and licensed in Spain. Copyright 2025 JCN Newswire via SeaPRwire.com.
TOKYO & JAKARTA, May 27, 2025 - (JCN Newswire via SeaPRwire.com) - JCB International Co., Ltd., the international operations subsidiary of JCB Co., Ltd., Japan's only international payment brand (hereinafter collectively referred to as “JCB”), has entered into a Memorandum of Understanding (MoU) with Noage International Inc. (hereinafter "NI"), a company engaged in medical and health checkup services. This partnership aims to expand the JCB Advanced Medical Tourism Program, which has been promoting advanced medical tourism to Japan for affluent Indonesians since 2023.On the same occasion, NI also signed an MoU with PT Bank Danamon Indonesia Tbk. As a result, Danamon Privilege Banking customers who hold Danamon JCB Precious Cards will receive the special service benefits of the JCB Exclusive Medical Tourism Program—benefits that are also available to JCB Indonesia Ultimate cardholders.Partnership OverviewMedical tourism is becoming increasingly popular among Indonesia's affluent segment, who are increasingly traveling abroad to access advanced medical services. While Singapore and Malaysia remain top destinations, Japan continues to face challenges, such as language barriers that limit access to its medical services.To overcome these challenges, JCB launched the JCB Advanced Medical Tourism Program in October 2023, initially offering services in Osaka for its affluent Indonesian cardmembers. In August 2024, the program expanded to Tokyo, further enhancing access to high-quality medical care in Japan.Through this partnership, JCB is expanding its services to offer cardmembers the option of receiving care at either Tokyo Midtown Clinic (Roppongi) or Nihonbashi Muromachi Mitsui Tower Midtown Clinic, both of which are affiliated with NI. Additionally, Ultimate cardmembers holding JCB Cards issued in Indonesia will be eligible for complimentary health checkup services at these two facilities.*English-language support will be provided throughout the entire process—from preliminary consultations to medical feedback—ensuring that cardmembers can receive continuous medical care with peace of mind.Furthermore, through JCB’s partner travel agency in Indonesia, assistance will be provided for all necessary arrangements related to medical visits to Japan, including flights, accommodations, and transportation. A special hospitality program will also be offered, featuring personalized sightseeing arrangements and access to JCB's exclusive privileges in Japan.*The health checkup provided by NI will be offered free of charge. However, to receive this service, cardmembers must select a health checkup option from the available menu (starting at 44,000 yen including tax). Further information is available at https://bit.ly/jcb_noageBackground of the MemorandumJCB has been issuing JCB Cards in Indonesia in collaboration with nine partners, primarily major banks, targeting affluent customers.With "Japanese hospitality (Omotenashi)" as the cornerstone of our global brand value, JCB has adopted “SUGOI JAPAN” as a key phrase in Indonesia. By fostering strong partnerships with numerous Japanese companies across both Indonesia and Japan, and leveraging its brand presence, JCB delivers the unique value of Japan to its cardmembers.This partnership with NI was made possible by the shared commitment of both companies to providing Japanese quality medical services in the Indonesian market.JCB will continue to enhance its distinctive and unique value under the "SUGOI JAPAN" initiative and strive to become the brand of choice for its cardmembers.The Concept of SUGOI JAPANJCB offers a range of exclusive services centered around the themes of "Japan" and "unique to JCB," based on three core concepts: "VISIT JAPAN," "JCB DAY," and "JAPAN DINNING.” JCB aims to ensure that its services are easy to understand and use for all cardmembers.Note: These services are limited to JCB Cards issued in Indonesia.About Noage InternationalNI is a company that aims to achieve “age-defying health and longevity,” a vision reflected in its name, “No age.” The company provides high-quality medical services for international patients at facilities, such as Tokyo Midtown Clinic.NI is committed to helping all customers lead healthy and fulfilling lives by offering personalized support that transcends language barriers. To achieve this, NI has developed a multilingual medical translation system powered by generative AI, enabling overseas patients to access medical services in Japan with peace of mind. (https://id.no-age.com/)About JCBJCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 56 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 169 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide. For more information, please visit: https://bit.ly/JCBIndonesiaJPNContactAnna TakedaCorporate CommunicationsTel: +81-3-5778-8353Email: jcb-pr@info.jcb.co.jpAbout DanamonPT Bank Danamon Indonesia Tbk (“Danamon”) is one of Indonesia’s largest private-owned commercial banks with consolidated total assets of Rp250.8 trillion. With a vision of “We Care and Enable Millions to Prosper,” Danamon provides holistic financial solutions tailored for the needs of retail, small and medium enterprises, corporate, and financial institution customers. As a member of MUFG, one of the largest global financial groups, Danamon’s strength is supported by MUFG Bank, Ltd. as its parent entity, MUFG’s subsidiaries and partner banks in Southeast Asia, and group members in Indonesia: Adira Finance, Home Credit Indonesia, Mandala Finance, Zurich Asuransi Indonesia, alongside its other strategic partners.With more than 24,000 employees (consolidated), 870 branches (conventional, Sharia Business Unit, and Adira Finance) and 1.016 ATMs and CRMs across Indonesia alongside 60,000 ATM Bersama, PRIMA, and ALTO networks, online banking through D-Bank PRO for retail customers and Danamon Cash Connect for corporate customers, and Hello Danamon 1-500-090 24-hour contact center, Danamon is committed to growing together as One Financial Group, to become a trusted customer-centric financial partner, serve all stakeholders, and run a sustainable business for a better future for Indonesia.Danamon is listed on Indonesia Stock Exchange with the ticker code BDMN. MUFG Bank, Ltd. is Danamon’s controlling shareholder, owning 92.47% of Danamon’s shares (directly and indirectly). For further information, visit Danamon’s website, www.danamon.co.id.Note: Data as of March 31, 2025For more information, please contact:Tarida FransiskaCorporate Communications ManagerPT Bank Danamon Indonesia TbkEmail: tarida.fransiska@danamon.co.id Copyright 2025 JCN Newswire via SeaPRwire.com.
TOKYO, May 27, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) and the Ministry of Energy of Uzbekistan (MOE) have signed a Memorandum of Understanding (MOU) to conduct a joint study of a power development plan with stable power source needs, including the potential upgrade of the country's gas turbine fleet with hydrogen co-firing capability as well as other technologies that can contribute to decarbonization.Under this MOU, both entities have been working on the following three items:- Evaluation of an upgrade for existing power plants leveraging MHI equipment, to meet necessary parameters;- Evaluation of new gas turbine combined cycle (GTCC) plants, including hydrogen co-firing and scope of necessary modifications;- Capacity planning with latest technologies.The program was officially launched after the agreement on the detailed work plan between the MOE and MHI, and will continue for two years with financial support from the Ministry of Economy, Trade and Industry (METI) of Japan.Uzbekistan's government recently published its plan for introducing renewable power by 2030, which aims to achieve a generation ratio for renewables of more than 54% by that date. MHI has supplied systems for thermal power generation installations in Uzbekistan which are contributing toward generating stable power as demand increases; and which also offer a variety of decarbonization technologies such as hydrogen co-firing and carbon capture, utilization and storage (CCUS). Through this program, the MOE and MHI will evaluate the current plan and determine necessary countermeasures, including implementation of new systems and the modification of the current gas turbine fleet to supplement renewables introduction and promote further decarbonization.In January 2024, METI and the MOE concluded a Memorandum of Cooperation (MOC) to promote and enhance Japan-Uzbekistan energy cooperation in an effort to achieve a realistic energy transition that takes advantage of all available energy sources, technologies, and options, including energy conservation; renewable energy; hydrogen; ammonia; e-fuels; CCUS, carbon recycling; and highly efficient power generation technology. This program is in line with this MOC and promotes further collaboration between both countries.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.
- The Asia Summit on Global Health (ASGH) gathers over 80 government officials and organisations, research pioneers, investors, and business leaders to explore international collaboration on medical technology, silver health, and healthcare systems. A dedicated “Silver Health Chapter” debuts this year to spotlight the ageing population.- Renowned speakers include Prof John Hardy, the “father of Alzheimer’s disease genetic studies”; Dr Victor Yosef Melt Campos, Chair (2024-2025) of APEC Health Working Group and General Director of International Cooperation at the Ministry of Health of Peru; and Martin Taylor, Representative to China of the World Health Organization. They will share insights on the latest developments in medical innovation.- The Hong Kong International Medical and Healthcare Fair (Medical Fair) focuses on MedTech, GeronTech, and green solutions, featuring the latest medical health devices, products, and solutions including many AI-powered innovations.- The Medical Fair has attracted some 300 exhibitors from 13 countries and regions. Participating with pavilions for the first time are Israel, Thailand, and the UK, along with debut exhibitors from Singapore, Germany, Italy and Luxembourg.HONG KONG, May 26, 2025 - (ACN Newswire via SeaPRwire.com) – International Healthcare Week (IHW), organised by the Hong Kong Trade Development Council (HKTDC), officially opened today. One of its flagship events, the fifth Asia Summit on Global Health (ASGH), takes place today and tomorrow (26 and 27 May) at the Hong Kong Convention and Exhibition Centre (HKCEC). Under the theme Fostering Global Collaboration for a Shared Future, the summit brings together more than 80 healthcare leaders and experts from around the world to explore the future direction of the industry and collaboration opportunities. Another flagship event, the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), also kicks off today (26 to 28 May), and features some 300 exhibitors from 13 countries and regions, showcasing cutting-edge MedTech, GeronTech, and green solutions, including many AI-powered innovations, to foster global industry collaboration.The ASGH opened with welcome remarks delivered by HKTDC Chairman Dr Peter K N Lam. “The global health sector is currently facing challenges, including a resurgence in infectious diseases, coupled with the growing needs of an ageing population and ongoing health equity concerns. These issues demand urgent attention and collective action to protect communities worldwide. Now in its fifth edition, ASGH is a key event for the global healthcare industry, and we are proud that connections made through ASGH have enabled many new investments and collaborations in healthcare innovation. Alongside ASGH, the Hong Kong International Medical and Healthcare Fair is taking place. There, you will find the latest HealthTech solutions from around the globe, with a particular focus on hospital equipment, rehabilitation, elderly care and biotech. As anchor events of the International Healthcare Week, ASGH and Medical Fair highlights Hong Kong’s commitment to working with partners to nurture an innovative health and medical sector,” Dr Lam said.In his opening speech, Hong Kong SAR Chief Executive John Lee said: "Under the theme of "Fostering Global Collaboration for a Shared Future", this summit reaffirms Hong Kong's pivotal role as a leading health innovation hub in the region. Under the "one country, two systems" principle, Hong Kong enjoys unique connectivity with both Mainland China and the world. As the world's freest economy and one of the top three international financial centres, we offer an efficient, open and fair business environment with robust intellectual property protection. We maintain free flows of information, capital, goods and talent. We are also emerging as a leading hub for scientific innovation, technological advancement and world-class education.”Prof Cao Xuetao, Vice-Minister of the National Health Commission of the People’s Republic of China, gave special remarks, noting: "China continues to open up and welcomes leading foreign-owned hospitals into the market through investment or joint ventures. We hope that our global partners can further localise and upgrade their mid-to-high-end products, resulting in win-win outcomes for all.”Additionally, Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), delivered remarks at the opening session via video link and stated, “The theme of ASGH could not be more appropriate given the challenges facing global health at the moment. The WHO Pandemic Agreement has been adopted recently. It was negotiated over the past three and a half years and shows a true spirit of international collaboration for global health. By working together, we can build a healthier, safer, and fairer world for all.”Global industry leaders gather to explore opportunities for international collaborationToday's Plenary Session I: Shaping a More Equitable and Sustainable Health System, featured keynote remarks by Prof Lo Chung-mau, Secretary for Health of the HKSAR Government, and Feng Haicang, Level I Bureau Rank Official of Department of Consumer Goods Industry, Ministry of Industry and Information Technology of the People's Republic of China. Prof Lo Chung-mau, stated: “A sustainable health system requires talents and enough healthcare manpower. While the Government has been addressing the issue of manpower shortage through a multipronged strategy, by increasing the number of intakes for local universities and admitting qualified non-locally trained healthcare workers, the 2024 Policy Address announced that the Government supports the plan to establish a third medical school. Indeed, Hong Kong has already hosted two top 30 world class medical schools but we have the ability and the need to develop the third one which shall adopt an innovative strategic positioning in pursuit of complementary development with the two existing ones.” The session was moderated by Prof Tsui Lap-chee, Chairman of the University of Hong Kong Foundation for Educational Development and Research, focused on key issues faced by healthcare systems in addressing global challenges. Distinguished speakers included Martin Taylor, Representative to China of the WHO; and Prof Nancy Ip, President of the Hong Kong University of Science and Technology. They shared valuable experiences and forward-looking insights to inspire the global healthcare field.Prof Nancy Ip noted: “Universities are more than academic institutions. They are global connectors, neutral platforms, and also engines of innovation, uniquely positioned to bridge divides between disciplines, industries, and also nations.”Distinguished international speakers of Plenary Session II: Fostering Global Collaboration for a Shared Future included Ambassador George Hara, Group Chairman and CEO of DEFTA Partners and former Special Advisor to the Cabinet Office of the Prime Minister of Japan. They jointly explored trends in global healthcare collaboration, injecting new ideas into constructing a more synergistic global healthcare landscape.The summit invited Prof John Hardy, known as the “father of Alzheimer’s disease genetic studies”, Chair of Molecular Biology of Neurological Disease of UCL Queen Square Institute of Neurology, to share his outlook on future research and treatment of neurodegenerative diseases such as Alzheimer's in the Dialogue with Global Pioneer in Health session.Prof John Hardy remarked: “For Alzheimer's treatment, I think that two changes can happen quite quickly: improvements in earlier diagnosis, and development of drugs that bypass the blood vessel-based amyloid. What we want to do with drugs is slow decline. If we understand what underpins that decline, it gives us targets, and we’re very excited by some of the findings in that area now.”“Healthy China 2030” serves as the national blueprint for healthcare policy development in Mainland China. In the session Beyond “Healthy China 2030”: Driving Health Innovation, Dr Zhang Lianshan, Executive Vice President, Jiangsu Hengrui Pharmaceuticals Co., Ltd.; and Marc Horn, Executive Vice President of Merck and President of Merck China, explored opportunities in the mainland healthcare market, analysing emerging trends in China's healthcare innovation ecosystem to open new pathways for international collaboration with other speakers.Diverse topics converge with forward-looking insights and the Silver Health Chapter explores new business opportunitiesFor the first time, the summit co-organised two thematic sessions with the Hong Kong University of Science and Technology under the overarching theme Shaping the Future of Healthcare. Speakers included Prof Graham Cooke, Vice-Dean (Research) of Faculty of Medicine at Imperial College London. They focused on the potential of AI in the medical field, sharing with participants how innovative technologies are driving new breakthroughs in healthcare. Additionally, sessions on Peeking into the Future of Gene and Cell Therapies and Women’s Health in Focus were also closely aligned with global medical development trends.Continuing today's in-depth dialogues, more exciting sessions will be presented tomorrow. For the first time, the summit will feature a Silver Health Chapter focusing on addressing the challenging ageing societies. Speakers including Prof James L. Kirkland, Director of Cedars-Sinai’s Centre for Advanced Gerotherapeutics, will gather at tomorrow morning's session Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology to delve into how to address the challenges brought by an ageing population, analysing future development trends and potential investment opportunities in the silver economy market.Furthermore, globally renowned speakers will be present tomorrow to share their valuable experiences and insights. Wyman Li, Chief Operating Officer of HKSH Medical Group; Prof Karim Asehnoune, President of National Committee for Public Hospital Research (CNCR), and other speakers will analyse how to promote the sustainable development of the healthcare industry through collaboration among different stakeholders in the session, Reinventing the Business of Healthcare through Partnerships. Prof Xu Hongxi, Distinguished Professor and Honorary Dean of Shanghai University of Traditional Chinese Medicine and other guests will discuss the latest developments and commercial potential of integrating Chinese and Western medicine in the session The Convergence of Chinese and Western Medicine in Global Health. Sessions on The Next Wave of Innovations in Neuroscience, Data-driven Healthcare Transforming Patient Journey and The Changing Face of Cancer will also be held tomorrow.A global platform for healthcare resource matchmaking to foster opportunities for innovative collaborationIn addition to thematic discussions, the summit also aims to bridge global collaboration among participants. For example, the ASGH Deal-making facilitates one-on-one meetings both online and offline, aiming to connect investors and projects in the healthcare sector from around the world to promote global collaborations.The summit has established the ASGH Business Hub, which brings together more than 170 innovative technology companies and award-winning projects from 13 countries and regions, including the mainland (Shanghai and Xiamen), Australia, and Thailand. The InnoHealth Showcase serves as a platform to explore business opportunities and innovative solutions and highlights more than 70 healthcare start-ups and projects led by the Innovation and Technology Commission, Cyberport, and six local universities. The showcase is structured around four key categories: pharmaceuticals and therapeutics, AI and Digital Health, medical devices and diagnostics, and community health and wellness. As part of the “Silver Health Chapter”, some of the showcased projects address the challenges of an ageing population, including early blood tests for Alzheimer’s disease, demonstrating cutting-edge capabilities and market potential in elderly healthcare.Integrating global innovations to showcase the future of healthcareThe Hong Kong International Medical and Healthcare Fair also opened today, organised by the HKTDC and co-organised by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA). Under the theme Innovations Boosting Smart Health Experience, this year’s Fair focuses on three key areas: MedTech, GeronTech and green solutions, featuring the latest medical health devices, products, and solutions.In the field of MedTech, UK exhibitor London Medical Exchange (Booth No: 3F-H15) presents a fully automated AI-powered patient monitoring system designed to improve patient care, transforming healthcare from reactive to proactive. Meanwhile, C2iTech (Booth No: 3F-G04), established by a research team from the School of Public Health at The University of Hong Kong, showcases a Respiratory Organoid Platform (ROP). By analysing nasopharyngeal or throat saliva samples from individuals, the platform predicts their likely response to respiratory virus infections, enabling more precise and personalised treatment by healthcare professionals.In the GeronTech segment, Medmind Technology (Booth No: 3F-G04), from the Hong Kong Science and Technology Parks Corporation (HKSTP) Pavilion, introduces an app for cognitive impairment assessment. The tool allows middle-aged and elderly users to play digital mahjong and other games, with AI used to assess their cognitive status and offer personalised brain training, helping prevent and detect early signs of cognitive decline. The system can also monitor patient conditions over time.The Hong Kong Council of Social Service (HKCSS), participating in the fair for the first time, is showcasing a range of GeronTech and related products, covering areas such as rehabilitation and mobility assistance, cognitive impairment support for patients and carers, and smart home solutions. HKCSS is also introducing its GeronTech education and rental services, along with its online platform that enables the public to learn about and hire GeronTech equipment. Users such as the elderly, people in rehabilitation, and carers can try out products, and rent or purchase them as needed, with support from a cross-disciplinary professional team. Through the Medical Fair, HKCSS aims to attract collaboration with other businesses to expand its services and benefit a wider segment of the community.For green solutions, MassPhoton (Booth No: 3F-H18), also from the HKSTP Pavilion, presents an ultraviolet disinfection system that combines semiconductor and smart control technologies, delivering more efficient and energy-saving disinfection for air, water and surfaces.This year’s Medical Fair has attracted some 300 exhibitors from 13 countries and regions. Participating with pavilions for the first time are Israel, Thailand, and the UK, along with debut exhibitors from Singapore, Germany, Italy and Luxembourg. Highlighting Hong Kong’s strength in medical innovation, seven local universities, over 30 innovative technology companies at the HKSTP pavilion, and more than 20 medical enterprises brought by the HKMHDIA are participating.The exhibition features a range of thematic zones, including Biotechnology, Hospital Equipment, Rehabilitation and Elderly Care Products, and Start-up and HKMHDIA zones. Highlight exhibits include AI-powered rehabilitation systems, portable ultrasound diagnostic systems, and smart hospital robots, demonstrating the frontiers of medical and healthcare technology.During the Medical Fair, there will be forums, seminars and networking receptions. Two forums focused on the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) healthcare sector will take place tomorrow. The morning forum titled The MedTech Nexus of the Greater Bay Area, which is co-organised with the HKMHDIA, will feature industry experts sharing insights on intellectual property strategies for biomedical innovation, ways to integrate resources for GBA market development, and successful experiences in promoting medical technology in the GBA. The afternoon forum titled The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area will bring together experts from the Greater Bay Area Centre for Medical Device Evaluation and Inspection of National Medical Products Administration, the Medical Device Division of Department of Health, and SGS-CSTC Standards Technical Services Co., Ltd., to explore the latest developments, administrative systems and regulations in relevant fields, promoting cross-regional regulatory collaboration and fostering innovation through idea exchange.Using the HKTDC EXHIBITION+ hybrid model, global exhibitors, industry professionals, and buyers can continue business matching via the Click2Match smart business matching platform until 4 June, encouraging more cooperation.Aside from ASGH and the Medical Fair, IHW also features the Hospital Authority Convention, among many other industry events.Photo download: https://bit.ly/43xCK2bThe fifth Asia Summit on Global Health, jointly organised by the Hong Kong SAR Government and the Hong Kong Trade Development Council takes place at the Hong Kong Convention and Exhibition Centre from 26 to 27 May 2025 under the theme Fostering Global Collaboration for a Shared FutureDr Peter K N Lam, HKTDC Chairman, gives a welcome addressJohn Lee, Chief Executive of the Hong Kong SAR, delivers opening remarksProf Cao Xuetao, Deputy Director of the National Health Commission of the People’s Republic of China, delivers special remarksDr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation, delivers remarks at the opening session via video linkThe summit invites Prof John Hardy, Chair of Molecular Biology of Neurological Disease at UCL Queen Square Institute of Neurology. As an internationally renowned neurogeneticist, and Brain Prize recipient for "groundbreaking research on the basis of Alzheimer's disease", Prof John Hardy is known as the “father of Alzheimer’s disease genetic studies”ASGH deal-making facilitates one-on-one meetings both online and offline, aiming to bridge investors with healthcare projects from around the world and promote global collaborationASGH facilitates the signing of the partnership agreements, fostering concrete collaboration in various areas of the healthcare industry.The 16th Hong Kong International Medical and Healthcare Fair, themed Innovations Boosting Smart Health Experience, focuses on three key areas: MedTech, GeronTech and green solutions, featuring the latest medical health devices, products, and solutionsMedmind Technology, from Hong Kong Science and Technology Parks Corporation (HKSTP) Pavilion, introduces an app for cognitive impairment assessment. The tool allows middle-aged and elderly users to play digital mahjong and other games, with AI used to assess their cognitive status and offer personalised brain training, helping prevent and detect early signs of cognitive declineThe Hong Kong Council of Social Service (HKCSS), participating in the fair for the first time, showcases a range of GeronTech products, covering areas such as rehabilitation and mobility assistance, cognitive impairment support for patients and carers, and smart home solutionsThe Hungarian pavilion is once again participating in the Medical Fair, bringing devices for health assessment and medical-related coursesWebsitesInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enAsia Summit On Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/enProgramme: https://www.asiasummitglobalhealth.com/conference/asgh/en/programmeSpeakers: https://www.asiasummitglobalhealth.com/conference/asgh/en/speakerHong Kong International Medical and Healthcare Fair:https://www.hktdc.com/event/hkmedicalfair/enList of products: https://www.hktdc.com/event/hkmedicalfair/en/productActivity schedule: https://www.hktdc.com/event/hkmedicalfair/en/intelligence-hubMedia enquiriesFor enquiries, please contact Yuan Tung Financial Relations Limited:Louise SongTel: (852) 3428 5691Email: lsong@yuantung.com.hkTiffany LeungTel: (852) 3428 2361Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Asia Summit on Global HealthSharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgJane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgHong Kong International Medical and Healthcare FairKelly ShekTel: (852) 2584 4537Email: kelly.yt.shek@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgMedia Room: http://mediaroom.hktdc.com Copyright 2025 ACN Newswire via SeaPRwire.com.
BRATISLAVA, May 26, 2025 - (ACN Newswire via SeaPRwire.com) - The Council of Slovak Exporters welcomes the launch of the European Commission’s public consultation, announced in early May, focused on potential response measures regarding certain imported goods from the United States, should ongoing discussions on transatlantic economic cooperation not lead to a mutually beneficial outcome. Topics under consultation may include trade flows in sectors such as steel scrap and chemical products. The consultation will close on 10 June, coinciding with the Visegrad 4 Business Conference in Bratislava, where regional business leaders will convene to address global economic relations, EU market resilience, and other key issues critical to regional competitiveness."It is indeed symbolic that these consultations with the European Commission, which represent a much-needed link between the private and public sectors, are culminating on the day of our Visegrad 4 Business Conference, which aims to do exactly the same: To achieve demand-driven public policies and measures that will help Europe's industry and exports from losing global competitiveness." – said Lukáš Parízek, founder of the Visegrad 4 Business Conference and Chairman of the Council of Slovak Exporters.Top industry representatives from various sectors, as well as public officials and representatives of foreign diplomatic missions, have already confirmed their participation in this key regional business event. The conference, organized in the premises of the Bratislava Castle, will be opened with a speech by the Speaker of the Parliament Richard Raši. Maros Sefcovic, European Commissioner for Trade and Economic Security, will deliver his remarks and speak in an exclusive format during the first part of the day, as well as attend a roundtable discussion with industry leaders from the V4 region. Slovak Foreign Minister Juraj Blanár and Hungarian Foreign Minister Péter Szijjártó have also confirmed their participation in the closing part of the conference.Visegrad 4 Business Conference is jointly organised since 2022 by four business organisations from the V4 region: Council of Slovak Exporters, Czech Association of Exporters, Hungarian business association MAPI Klub and Polish Economic Forum. The conference is organised with the support of the International Visegrad Fund, individual V4 governments and private sponsors.For more information visit www.visegrad4business.eu.About the Council of Slovak ExportersThe Council of Slovak Exporters was established in 2020 as a response to COVID-19's impact on local businesses. With over 130 supporting companies, this business platform connects exporters and facilitates dialogue with state institutions, international organizations, and financial institutions. The Council publicly communicates in support of Slovak exporters, provides export-related assistance, organizes networking events, and connects relevant entities in international trade. The organization holds BRONZE "European Cluster Excellence Initiative" certification, operating at the European level.Social LinksX: https://x.com/Visegrad4BInstagram: https://www.instagram.com/visegrad4business/LinkedIn: https://www.linkedin.com/company/visegrad-4-business/Facebook: https://www.facebook.com/visegrad4business#Media ContactCouncil of Slovak ExportersVisegrad 4 Business Conference+421 914 201 101https://www.visegrad4business.eu/ Copyright 2025 ACN Newswire via SeaPRwire.com.
TOKYO, May 26, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced the launch of its new corporate venture capital fund, Fujitsu Ventures Fund II(1) (Fund II), with a total capital commitment of 15 billion yen, effective July 1, 2025. This fund will be managed through Fujitsu Ventures Limited(2).Since April 2021, Fujitsu has been driving innovation through the establishment and management of Fujitsu Ventures Fund LLC (Fund I). Through Fund I, Fujitsu has made strategic business investments in startups globally to strengthen business collaboration aligned with its corporate strategy. Additionally, from June 2024, Fujitsu initiated impact investing, targeting startups that address social challenges. To date, Fund I has invested in a total of 17 companies and has achieved solid results in both strategic and financial aspects.Building on this foundation, Fund II will expand the scale of investments to enhance and develop these initiatives further. Fujitsu aims to accelerate innovation and contribute to the realization of a sustainable society through this new fund.Overview of Fund IIFund II will continue to invest in promising startups both domestically and internationally, following the approach of Fund I. Strategic business investments will focus on reinforcing business collaboration, while increasing investments in companies with cutting-edge technologies that hold potential for future business partnerships. This will accelerate Fujitsu’s ability to incorporate emerging technologies and trends.For impact investments, Fund II will prioritize contributions to solving social issues through its portfolio companies, while seeking to generate synergistic value through collaboration with Fujitsu.(1) Fujitsu Ventures Fund II：Managed within Fujitsu Ventures Fund LLC.(2) Fujitsu Ventures Limited：Head office: Minato-ku, TokyoPresident & CEO: Hideaki YajimaAbout FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: global.fujitsu. Copyright 2025 JCN Newswire via SeaPRwire.com.
Kuala Lumpur, May 26, 2025 - (ACN Newswire via SeaPRwire.com) – CBL International Limited (NASDAQ: BANL) (“CBL” or the “Company”), the listing vehicle of Banle Group (“Banle” or the “Group”), a leading marine fuel logistics company in the Asia-Pacific region, today announced the official renaming of its Singapore-based wholly owned subsidiary, Majestic Energy (Singapore) Pte Ltd, to support its regional growth strategy.Effective immediately, Majestic Energy (Singapore) Pte Ltd has been officially renamed to Banle International (Singapore) Pte Ltd, reflecting the Group’s deepening commitment to the Singapore market and its strategic expansion into sustainable fuels.Singapore remains the world's largest bunkering hub, with annual sales close to 55 million metric tons in 2024, increased by 6% year-over-year as compared to 2023, according to Maritime & Port Authority of Singapore (“MPA”) statistics. While conventional fuels still dominate the market, demand for sustainable fuels such as biofuels, LNG, and methanol continues to rise steadily. Notably, biofuel sales in the first four months of 2025 in Singapore have already surpassed 50% of the total volume recorded in 2024, according to MPA statistics.As the primary fuel bunkering hub in the Asia-Pacific region, Singapore serves as a strategic base for CBL’s regional expansion. CBL’s revenue in Singapore increased by 102% year-over-year in 2024 as compared to 2023. In March 2025, the Company launched its first biofuel supply services in Singapore — a key regional port — as part of its broader initiative to offer sustainable fuel alternatives across the region, followed by biofuel supply in Malaysia, Hong Kong and various ports in China. CBL’s biofuel sales volumes and sales surged over 600% year-over-year in 2024, supported by strengthened supplier relationships and reliable supply chains. These efforts help customers meet IMO GHG targets while offering sustainable, cost-effective alternatives.“Singapore plays a pivotal role in our long-term growth strategy,” said Dr. Teck Lim Chia, Chairman and CEO of CBL. “The renaming of our subsidiary underscores our strengthened presence in this critical market and reinforces our commitment to supporting the global maritime industry’s transition toward greener energy solutions.”Despite the increasing competition in Singapore’s bunkering sector, CBL continues to differentiate itself through its agile operations and customer-centric approach. The Company prides itself on its ability to adapt and tailor solutions to meet the specific needs of clients and suppliers, enabling it to capture new opportunities in both traditional and emerging fuel segments.Christofel Tian, our Head of Singapore, added "With our rebranding to Banle International (Singapore) Pte Ltd, we are not only aligning ourselves more closely with the Group’s identity but also signaling our long-term commitment to the Singapore market. As the global bunkering landscape evolves, especially with the rapid adoption of sustainable fuels, we are well-positioned to grow alongside Singapore’s vision of becoming a leader in sustainable maritime solutions."With its robust regulatory environment, mature infrastructure, and strong government support, Singapore is well-positioned to maintain its leadership in the global bunkering market — and CBL is committed to growing alongside it.About the Banle GroupCBL International Limited (Nasdaq: BANL) is the listing vehicle of Banle Group, a reputable marine fuel logistic company based in the Asia Pacific region that was established in 2015. We are committed to providing customers with one-stop solution for vessel refueling, which is referred to as bunkering facilitator in the bunkering industry. We facilitate vessel refueling mainly through local physical suppliers in over 60 major ports covering Belgium, China, Hong Kong, India, Japan, Korea, Malaysia, Mauritius, Panama, the Philippines, Singapore, Taiwan, Thailand, Turkey and Vietnam, as of 16 April 2025. The Group actively promotes the use of sustainable fuels and is awarded with the ISCC EU and ISCC Plus certifications.For more information about our company, please visit our website at: https://www.banle-intl.com.Forward-Looking StatementsCertain statements in this announcement are not historical facts but are forward-looking statements. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “could,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan,” “should,” “would,” “plan,” “future,” “outlook,” “potential,” “project” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other performance metrics and projections of market opportunity. They involve known and unknown risks and uncertainties and are based on various assumptions, whether or not identified in this press release and on current expectations of the Company’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company. Some important factors that could cause actual results to differ materially from those in any forward-looking statements could include changes in domestic and foreign business, markets, financial, political and legal conditions, geopolitical disruptions and other events that result in material changes in fuel prices. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.CBL INTERNATIONAL LIMITED (Incorporated in Cayman Islands with limited liabilities)For more information, please contact: CBL International Limited Email: investors@banle-intl.comStrategic Financial Relations LimitedShelly Cheng Tel: (852) 2864 4857 Iris Au Yeung Tel: (852) 2114 4913 Email: sprg_cbl@sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.
AI-powered real-time deepfake detection solution, Aletheia, recognised for effectiveness, innovation, and operational scalabilityHONG KONG, May 27, 2025 - (ACN Newswire via SeaPRwire.com) - Ensign InfoSecurity (“Ensign”), one of Asia’s largest cybersecurity service providers, has won the “Product Excellence - Cybersecurity Product of the Year” award at the Tech Fest Hong Kong Awards 2025 for its proprietary solution, *Aletheia, an AI-powered real-time deepfake detection tool that enhances digital trust and protects organisations against multimedia-based deception.Developed by Ensign Labs, Aletheia uses multi-modal artificial intelligence to identify manipulated video and audio content. Available across endpoint software or a chrome browser plug-in, the solution delivers real-time detection to support secure virtual meetings, digital identity verification, and high-assurance communication environments.Built for operational environments, Aletheia performs all detection on-device, ensuring privacy-first analysis without cloud dependency. It integrates seamlessly with Security Information and Event Management (SIEM) systems to provide real-time alerts, enabling security teams to respond swiftly with forensic-ready evidence for investigation and resolution.“This award reinforces the purpose behind our work,” said Nicky Au, General Manager, Greater China Region, Ensign InfoSecurity (East Asia) Limited. “As threats grow more sophisticated, the ability to safeguard digital interactions, authentically and at speed, has become critical to business resilience and public trust.Cybersecurity is not achieved in isolation. It requires coordination, transparency, and shared intelligence. At Ensign, we are committed to working alongside our peers, partners, and clients to stay ahead of what’s next.”Aletheia is built to meet the evolving needs of sectors most vulnerable to digital deception. Examples of its use are varied. In financial services, it adds a line of defence during voice authentication and transaction validation. For media organisations, it supports source verification and editorial integrity. Government agencies can rely on it to validate emergency communications, while Human Resource departments use it to screen for audio-visual fraud in remote interviews and recruitment processes.This award underscores Ensign’s commitment to developing applied, scalable technologies through its in-house R&D. Aletheia is part of a broader portfolio of AI-powered capabilities that include cyber analytics, digital risk monitoring, and automated threat detection, designed to equip enterprises and public institutions with future-ready defence strategies.*Aletheia, in Greek mythology, refers to the Goddess of truth, symbolising the pursuit of truth and transparency.About Ensign InfoSecurityEnsign InfoSecurity is the largest cybersecurity service provider in Asia. Headquartered in Singapore, Ensign offers bespoke solutions and services to address their clients’ cybersecurity needs. Their core competencies are in the provision of cybersecurity advisory and assurance services, architecture design and systems integration services, and managed security services for advanced threat detection, threat hunting, and incident response. Underpinning these competencies is in-house research and development in cybersecurity. Ensign has two decades of proven track record as a trusted and relevant service provider, serving clients from the public and private sectors in the Asia Pacific region.For more information, visit www.ensigninfosecurity.com, or email media@ensigninfosecurity.com Copyright 2025 ACN Newswire via SeaPRwire.com.
